{"id":625268,"title":"Cover Letter - Guidance for Pre-manufacturing and Pre-exportation Notifications (C.07.011) under Canada's Access to Medicines Regime: Guide-0072 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T10:18:00.214000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/manufacturing-exportation-notifications-canada-access-medicines-regime-guide-0072.html","snippet":"Cover Letter - Guidance for Pre-manufacturing and Pre-exportation Notifications (C.07.011) under Canada's Access to Medicines Regime: Guide-0072 (December 1 st , 2007) Unit Name: Drug GMP Inspection Unit Telephone: 613-957-1492 Fax: 613-957-6709 Email:…","rawSnapshotUrl":"/api/snapshots/raw/625268","browseUrl":"https://replay.healtharchive.ca/job-6/20260227101800/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/manufacturing-exportation-notifications-canada-access-medicines-regime-guide-0072.html#ha_snapshot=625268","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}